CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro

Chimeric antigen receptor (CAR)-expressing macrophages (CAR-M) have a great potential to improve cancer therapy, as shown from several recent preclinical studies. However, unlike CAR-T cell therapy, which has been widely studied, the efficacy and limitations of CAR-M cells remain to be established....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Maoxuan, Liu, Junchen, Liang, Ziwei, Dai, Kun, Gan, Jiangyu, Wang, Qi, Xu, Yang, Chen, Youhai H., Wan, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688246/
https://www.ncbi.nlm.nih.gov/pubmed/36429120
http://dx.doi.org/10.3390/cells11223692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688246/
https://www.ncbi.nlm.nih.gov/pubmed/36429120
http://dx.doi.org/10.3390/cells11223692

Ejemplares similares